These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 15915389)
21. Indication of a role of plasminogen activator inhibitor type I in protecting murine fibrosarcoma cells against apoptosis. Rømer MU; Kirkebjerg Due A; Knud Larsen J; Hofland KF; Christensen IJ; Buhl-Jensen P; Almholt K; Lerberg Nielsen O; Brünner N; Lademann U Thromb Haemost; 2005 Oct; 94(4):859-66. PubMed ID: 16270643 [TBL] [Abstract][Full Text] [Related]
22. Expression of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor and plasminogen activator inhibitors in patients with renal cell carcinoma: correlation with tumor associated macrophage and prognosis. Ohba K; Miyata Y; Kanda S; Koga S; Hayashi T; Kanetake H J Urol; 2005 Aug; 174(2):461-5. PubMed ID: 16006865 [TBL] [Abstract][Full Text] [Related]
23. Urokinase-type plasminogen activator and plasminogen-activator-inhibitor type 1 predict metastases in good prognosis breast cancer patients. De Cremoux P; Grandin L; Diéras V; Savignoni A; Degeorges A; Salmon R; Bollet MA; Reyal F; Sigal-Zafrani B; Vincent-Salomon A; Sastre-Garau X; Magdelénat H; Mignot L; Fourquet A; Anticancer Res; 2009 May; 29(5):1475-82. PubMed ID: 19443353 [TBL] [Abstract][Full Text] [Related]
24. Functional plasminogen activator inhibitor-1 gene variants and breast cancer survival. Zhang X; Shu XO; Cai Q; Ruan Z; Gao YT; Zheng W Clin Cancer Res; 2006 Oct; 12(20 Pt 1):6037-42. PubMed ID: 17062678 [TBL] [Abstract][Full Text] [Related]
25. Plasminogen activator inhibitor-1 as a potential marker for the malignancy of colorectal cancer. Sakakibara T; Hibi K; Koike M; Fujiwara M; Kodera Y; Ito K; Nakao A Br J Cancer; 2005 Oct; 93(7):799-803. PubMed ID: 16091756 [TBL] [Abstract][Full Text] [Related]
26. Fracture healing in mice deficient in plasminogen activator inhibitor-1. Rundle CH; Wang X; Wergedal JE; Mohan S; Lau KH Calcif Tissue Int; 2008 Oct; 83(4):276-84. PubMed ID: 18820962 [TBL] [Abstract][Full Text] [Related]
27. Reduction of brain metastases in plasminogen activator inhibitor-1-deficient mice with transgenic ocular tumors. Maillard CM; Bouquet C; Petitjean MM; Mestdagt M; Frau E; Jost M; Masset AM; Opolon PH; Beermann F; Abitbol MM; Foidart JM; Perricaudet MJ; Noël AC Carcinogenesis; 2008 Nov; 29(11):2236-42. PubMed ID: 18753414 [TBL] [Abstract][Full Text] [Related]
28. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion. Hildenbrand R; Schaaf A Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473 [TBL] [Abstract][Full Text] [Related]
29. Plasminogen activator inhibitor -1 gene 4G/5G polymorphism in patients with breast cancer. Eroglu A; Ulu A; Cam R; Akar N J BUON; 2006; 11(4):481-4. PubMed ID: 17309181 [TBL] [Abstract][Full Text] [Related]
30. [Roles of serine proteases and matrix metalloproteinases in tumor invasion and angiogenesis]. Masson V Bull Mem Acad R Med Belg; 2006; 161(5):320-6. PubMed ID: 17283905 [TBL] [Abstract][Full Text] [Related]
31. Regulation of programmed cell death by plasminogen activator inhibitor type 1 (PAI-1). Lademann UA; Rømer MU Thromb Haemost; 2008 Dec; 100(6):1041-6. PubMed ID: 19132228 [TBL] [Abstract][Full Text] [Related]
32. Analysis of the invasion-metastasis mechanism in pancreatic cancer: involvement of plasmin(ogen) cascade proteins in the invasion of pancreatic cancer cells. Tan X; Egami H; Nozawa F; Abe M; Baba H Int J Oncol; 2006 Feb; 28(2):369-74. PubMed ID: 16391791 [TBL] [Abstract][Full Text] [Related]
33. Lack of association between level of Plasminogen Activator Inhibitor-1 and estimates of tumor angiogenesis in early breast cancer. Offersen BV; Riisbro R; Knoop A; Brünner N; Overgaard J; Acta Oncol; 2007; 46(6):782-91. PubMed ID: 17653901 [TBL] [Abstract][Full Text] [Related]
35. Adenovirus E1A orchestrates the urokinase-plasminogen activator system and upregulates PAI-2 expression, supporting a tumor suppressor effect. Fernández-Soria V; Lleonart ME; Diaz-Fuertes M; Villuendas R; Sánchez-Prieto R; Fabra A; Ramón Y Cajal S Int J Oncol; 2006 Jan; 28(1):143-8. PubMed ID: 16327990 [TBL] [Abstract][Full Text] [Related]
36. PAI-1 -675 4G/5G polymorphism as a prognostic biomarker in breast cancer. Lei H; Hemminki K; Johansson R; Altieri A; Enquist K; Henriksson R; Lenner P; Försti A Breast Cancer Res Treat; 2008 May; 109(1):165-75. PubMed ID: 17616807 [TBL] [Abstract][Full Text] [Related]
37. Protein C and its inhibitor in malignancy. Suzuki K; Hayashi T Semin Thromb Hemost; 2007 Oct; 33(7):667-72. PubMed ID: 18000793 [TBL] [Abstract][Full Text] [Related]
38. Mechanisms of TGF-beta1-induced intimal growth: plasminogen-independent activities of plasminogen activator inhibitor-1 and heterogeneous origin of intimal cells. Otsuka G; Stempien-Otero A; Frutkin AD; Dichek DA Circ Res; 2007 May; 100(9):1300-7. PubMed ID: 17431190 [TBL] [Abstract][Full Text] [Related]
39. Interaction between cancer cells and stromal fibroblasts is required for activation of the uPAR-uPA-MMP-2 cascade in pancreatic cancer metastasis. He Y; Liu XD; Chen ZY; Zhu J; Xiong Y; Li K; Dong JH; Li X Clin Cancer Res; 2007 Jun; 13(11):3115-24. PubMed ID: 17545513 [TBL] [Abstract][Full Text] [Related]